Exploring Artificial Intelligence Application in Export-Import Process: A Case Study from Indonesia
TEM Journal · 27.08.2025 · 2098-2110
DOI: 10.18421/tem143-17 ↗Kurz gefasst
Fachartikel in der Zeitschrift TEM Journal, online erschienen am 27.08.2025. Verfasst von Damar Aji Irawan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Binus University.
Abstract (Originalsprache)
This paper aims to explore how artificial intelligence (AI) is used in the export-import process in Indonesia combining diffusion of innovation (DIT) with comparative advantage theory. Previous studies on the use of artificial intelligence in export-import mainly focused on the features and potential usage of artificial intelligence. This study provides an actual case of how artificial intelligence is used in the export-import process in Indonesia. This research is qualitative using unstructured interviews with exporters, freight forwarders, logistic companies, and Indonesian customs. The results showed that artificial intelligence is in the experiment phase for exporters, freight forwards, and logistic companies, while for Indonesian customs, artificial intelligence is used to provide relative advantage.
Förderung
- Binus University
Zitieren
APA
Irawan, D. A., Nurcahyo, R., & Anita, T. L. (2025). Exploring Artificial Intelligence Application in Export-Import Process: A Case Study from Indonesia. TEM Journal, 2098-2110. https://doi.org/10.18421/tem143-17
Vancouver
Irawan DA, Nurcahyo R, Anita TL. Exploring Artificial Intelligence Application in Export-Import Process: A Case Study from Indonesia. TEM Journal. 2025:2098-2110. doi:10.18421/tem143-17
BibTeX
@article{Irawan2025,
author = {Irawan, Damar Aji and Nurcahyo, Rianto and Anita, Tiurida Lily},
title = {Exploring Artificial Intelligence Application in Export-Import Process: A Case Study from Indonesia},
journal = {TEM Journal},
year = {2025},
pages = {2098--2110},
doi = {10.18421/tem143-17}
}
EUVIMED